These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 23190903)

  • 1. Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma.
    Chren MM; Linos E; Torres JS; Stuart SE; Parvataneni R; Boscardin WJ
    J Invest Dermatol; 2013 May; 133(5):1188-96. PubMed ID: 23190903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence after treatment of nonmelanoma skin cancer: a prospective cohort study.
    Chren MM; Torres JS; Stuart SE; Bertenthal D; Labrador RJ; Boscardin WJ
    Arch Dermatol; 2011 May; 147(5):540-6. PubMed ID: 21576572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor recurrence of keratinocyte carcinomas judged appropriate for Mohs micrographic surgery using Appropriate Use Criteria.
    Stuart SE; Schoen P; Jin C; Parvataneni R; Arron S; Linos E; Boscardin WJ; Chren MM
    J Am Acad Dermatol; 2017 Jun; 76(6):1131-1138.e1. PubMed ID: 28365039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence of basosquamous carcinoma after Mohs micrographic surgery.
    Skaria AM
    Dermatology; 2010; 221(4):352-5. PubMed ID: 20924160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes in intermediate-risk squamous cell carcinomas treated with Mohs micrographic surgery compared with wide local excision.
    Xiong DD; Beal BT; Varra V; Rodriguez M; Cundall H; Woody NM; Vidimos AT; Koyfman SA; Knackstedt TJ
    J Am Acad Dermatol; 2020 May; 82(5):1195-1204. PubMed ID: 31887322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors and Rate of Recurrence after Mohs Surgery in Basal Cell and Squamous Cell Carcinomas: A Nationwide Prospective Cohort (REGESMOHS, Spanish Registry of Mohs Surgery).
    Tomás-Velázquez A; Sanmartin-Jiménez O; Garcés JR; Rodríguez-Prieto MA; Ruiz-Salas V; De Eusebio-Murillo E; Miñano-Medrano R; Escutia-Muñoz B; Flórez-Menéndez Á; Artola-Igarza JL; Alfaro-Rubio A; Gil P; Delgado-Jiménez Y; Sanchez-Schmidt JM; Allende-Markixana I; Alonso-Pacheco ML; García-Bracamonte B; De la Cueva-Dobao P; Navarro-Tejedor R; Ciudad-Blanco C; Carnero-González L; Vázquez-Veiga H; Cano-Martínez N; Vilarrasa-Rull E; Sanchez-Sambucety P; López-Estebaranz JL; Botella-Estrada R; Gonzalez-Sixto B; Martorell-Calatayud A; Morales-Gordillo V; Toll-Abelló A; Ocerin-Guerra I; Mayor-Arenal M; Suárez-Fernández R; Sainz-Gaspar L; Descalzo MA; García-Doval I; Redondo P;
    Acta Derm Venereol; 2021 Nov; 101(11):adv00602. PubMed ID: 34694418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanomas of the head and neck have high-local recurrence risk features and require tissue-rearranging reconstruction more commonly than basal cell carcinoma and squamous cell carcinoma: A comparison of indications for microscopic margin control prior to reconstruction in 13,664 tumors.
    Fix W; Etzkorn JR; Shin TM; Howe N; Bhatt M; Sobanko JF; Miller CJ
    J Am Acad Dermatol; 2021 Aug; 85(2):409-418. PubMed ID: 30458206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of non-melanoma skin cancers of the cutaneous perioral and vermilion lip treated by Mohs micrographic surgery.
    Queen D; Knackstedt T; Polacco MA; Collins LK; Lee K; Samie FH
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):305-311. PubMed ID: 30284728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of periocular basal cell carcinoma and squamous cell carcinoma after Mohs micrographic surgery: a retrospective cohort study.
    Weesie F; Naus NC; Vasilic D; Hollestein LM; van den Bos RR; Wakkee M
    Br J Dermatol; 2019 May; 180(5):1176-1182. PubMed ID: 30536656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence rates of cutaneous squamous cell carcinoma of the head and neck after Mohs micrographic surgery vs. standard excision: a retrospective cohort study.
    van Lee CB; Roorda BM; Wakkee M; Voorham Q; Mooyaart AL; de Vijlder HC; Nijsten T; van den Bos RR
    Br J Dermatol; 2019 Aug; 181(2):338-343. PubMed ID: 30199574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and histologic features of 141 primary basal cell carcinomas of the periocular region and their rate of recurrence after surgical excision].
    Spraul CW; Ahr WM; Lang GK
    Klin Monbl Augenheilkd; 2000 Oct; 217(4):207-14. PubMed ID: 11098454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mohs micrographic surgery local recurrences.
    Hruza GJ
    J Dermatol Surg Oncol; 1994 Sep; 20(9):573-7. PubMed ID: 8089356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence rates of primary nonmelanoma skin cancers treated by surgical excision compared to electrodesiccation-curettage in a private dermatological practice.
    Werlinger KD; Upton G; Moore AY
    Dermatol Surg; 2002 Dec; 28(12):1138-42; discussion 1142. PubMed ID: 12472494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curettage prior to Mohs' micrographic surgery for previously biopsied nonmelanoma skin cancers: what are we curetting? Retrospective, prospective, and comparative study.
    Jih MH; Friedman PM; Goldberg LH; Kimyai-Asadi A
    Dermatol Surg; 2005 Jan; 31(1):10-5. PubMed ID: 15720088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scalp tumors treated with Mohs micrographic surgery: clinical features and surgical outcome.
    Leibovitch I; Huilgol SC; Richards S; Paver R; Selva D
    Dermatol Surg; 2006 Nov; 32(11):1369-74. PubMed ID: 17083590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma.
    Chren MM; Sahay AP; Bertenthal DS; Sen S; Landefeld CS
    J Invest Dermatol; 2007 Jun; 127(6):1351-7. PubMed ID: 17301830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definitive radiotherapy versus Mohs surgery for early stage nonmelanoma skin cancers: a multi-institutional retrospective comparison of local recurrence.
    Gasalberti D; Ogrich L; Strasser J; Abdelmalek M
    Int J Dermatol; 2019 May; 58(5):e96-e98. PubMed ID: 30548841
    [No Abstract]   [Full Text] [Related]  

  • 18. Review and Update on Evidence-Based Surgical Treatment Recommendations for Nonmelanoma Skin Cancer.
    Shelton ME; Adamson AS
    Dermatol Clin; 2019 Oct; 37(4):425-433. PubMed ID: 31466583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mohs Surgery versus Standard Local Excision for Basal Cell Carcinoma, Squamous Cell Carcinoma, and Melanoma Skin Cancer.
    Johnson TM; Smith NR
    Facial Plast Surg; 2020 Apr; 36(2):133-140. PubMed ID: 32413920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of Mohs micrographic surgery.
    Stern RS
    J Invest Dermatol; 2013 May; 133(5):1129-31. PubMed ID: 23594532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.